BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8359865)

  • 1. Inhibitory effect of lipopolysaccharide-stimulated P388D1 macrophage-like cells on plasmacytoma cells.
    Tseng J; Ferng HC
    Immunol Invest; 1993 Jun; 22(4):283-300. PubMed ID: 8359865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecular mass inhibitor of growth of 3T3 cells and porcine aortic smooth muscle cells released from the macrophage cell line P388D1.
    McMurray HF; Proudfoot D; Davis JB; Parrott DP; Bowyer DE
    J Cell Sci; 1993 Dec; 106 ( Pt 4)():1301-11. PubMed ID: 8126109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
    Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
    Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dialysis culture system for the study of the production and modulation of growth-regulatory molecules: studies using the P388D1 macrophage cell line.
    Proudfoot D; Parrott DP; Bowyer DE
    J Cell Sci; 1995 Jan; 108 ( Pt 1)():379-86. PubMed ID: 7738113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the growth-inhibitory and apoptosis-inducing activities of a triterpene saponin, securioside B against BAC1.2F5 macrophages.
    Yui S; Kudo T; Hodono K; Mimaki Y; Kuroda M; Sashida Y; Yamazaki M
    Mediators Inflamm; 2003 Jun; 12(3):157-66. PubMed ID: 12857599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gp130 in human myeloma/plasmacytoma.
    Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
    Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine mediation of the suppressive effect of ferritin on colony-stimulating factor-1-dependent monocytopoiesis.
    Kreisberg R; Detrick MS; Osmand AP; Moore RN
    J Immunol; 1993 Jun; 150(11):5094-103. PubMed ID: 8496605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells.
    Nordan RP; Mock BA; Neckers LM; Rudikoff S
    Ann N Y Acad Sci; 1989; 557():200-5. PubMed ID: 2786694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
    J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.
    Nishihara T; Koga T; Hamada S
    Infect Immun; 1988 Nov; 56(11):2801-7. PubMed ID: 3262586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal tubule cells stimulated by lipopolysaccharide inhibit macrophage activation.
    Wang Y; Tay YC; Harris DC
    Kidney Int; 2004 Aug; 66(2):655-62. PubMed ID: 15253719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.
    Hayashida I; Hiramoto RN; Shrestha K; Ghanta VK
    Cancer Invest; 1989; 7(1):17-26. PubMed ID: 2567619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitro.
    Miura T; Ghanta VK; Hiramoto RN
    Cancer Invest; 1990; 8(1):17-25. PubMed ID: 2350718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
    Le J; Reis LF; Vilcek J
    Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
    Mizel SB; Oppenheim JJ; Rosentreich DL
    J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s).
    Sassa S; Wolpe S; Cerami A
    Blood Cells; 1987; 13(1-2):161-9. PubMed ID: 3478107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of macrophages and neutrophils by an endothelium growth suppressing factor.
    Matsunaga T; Usui S; Ukai S; Kiho T; Hirano K
    Biosci Biotechnol Biochem; 1999 Jul; 63(7):1228-37. PubMed ID: 10478450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
    Kodama K; Ghanta VK; Hiramoto NS; Hiramoto RN
    J Biol Response Mod; 1989 Aug; 8(4):385-96. PubMed ID: 2754437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of growth inhibitor from normal rabbit serum.
    Kimura T; Miyazaki K; Mashima K; Yamashita J; Horio T; Kakuno T
    J Biochem; 1991 Sep; 110(3):423-8. PubMed ID: 1769970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.
    Blankenstein T; Qin ZH; Uberla K; Müller W; Rosen H; Volk HD; Diamantstein T
    J Exp Med; 1991 May; 173(5):1047-52. PubMed ID: 2022919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.